ATE384804T1 - ZUSAMMENSETZUNGEN UND VERFAHREN ZUR BEHANDLUNG UND ZUR DETEKTION VON PROLIFERATIVEN STÖRUNGEN DIE MIT DER ÜBEREXPRESSION DES MENSCHLICHEN ßTRANSKETOLASE LIKE-1ß GENS IN ZUSAMMENHANG STEHEN - Google Patents

ZUSAMMENSETZUNGEN UND VERFAHREN ZUR BEHANDLUNG UND ZUR DETEKTION VON PROLIFERATIVEN STÖRUNGEN DIE MIT DER ÜBEREXPRESSION DES MENSCHLICHEN ßTRANSKETOLASE LIKE-1ß GENS IN ZUSAMMENHANG STEHEN

Info

Publication number
ATE384804T1
ATE384804T1 AT02008831T AT02008831T ATE384804T1 AT E384804 T1 ATE384804 T1 AT E384804T1 AT 02008831 T AT02008831 T AT 02008831T AT 02008831 T AT02008831 T AT 02008831T AT E384804 T1 ATE384804 T1 AT E384804T1
Authority
AT
Austria
Prior art keywords
methods
treatment
gene
overexpression
detection
Prior art date
Application number
AT02008831T
Other languages
English (en)
Inventor
Johannes Coy
Original Assignee
Coy Johannes Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Coy Johannes Dr filed Critical Coy Johannes Dr
Application granted granted Critical
Publication of ATE384804T1 publication Critical patent/ATE384804T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT02008831T 2002-04-19 2002-04-19 ZUSAMMENSETZUNGEN UND VERFAHREN ZUR BEHANDLUNG UND ZUR DETEKTION VON PROLIFERATIVEN STÖRUNGEN DIE MIT DER ÜBEREXPRESSION DES MENSCHLICHEN ßTRANSKETOLASE LIKE-1ß GENS IN ZUSAMMENHANG STEHEN ATE384804T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP20020008831 EP1354961B1 (de) 2002-04-19 2002-04-19 Zusammensetzungen und Verfahren zur Behandlung und zur Detektion von proliferativen Störungen die mit der Überexpression des menschlichen "Transketolase like-1" gens in Zusammenhang stehen

Publications (1)

Publication Number Publication Date
ATE384804T1 true ATE384804T1 (de) 2008-02-15

Family

ID=28459502

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02008831T ATE384804T1 (de) 2002-04-19 2002-04-19 ZUSAMMENSETZUNGEN UND VERFAHREN ZUR BEHANDLUNG UND ZUR DETEKTION VON PROLIFERATIVEN STÖRUNGEN DIE MIT DER ÜBEREXPRESSION DES MENSCHLICHEN ßTRANSKETOLASE LIKE-1ß GENS IN ZUSAMMENHANG STEHEN

Country Status (10)

Country Link
US (2) US7655398B2 (de)
EP (1) EP1354961B1 (de)
JP (1) JP4239824B2 (de)
CN (3) CN1646703A (de)
AT (1) ATE384804T1 (de)
AU (1) AU2003224067A1 (de)
CA (1) CA2480276C (de)
DE (1) DE60224778T2 (de)
ES (1) ES2298304T3 (de)
WO (1) WO2003089667A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2256500B1 (de) * 2005-03-07 2014-04-23 Dr. Johannes F. Coy Gebrauch von Inhibitoren des Enzyms TKTL1.
EP1701165A1 (de) * 2005-03-07 2006-09-13 Johannes Dr. Coy Therapeutischer und diagnostischer Gebrauch von TKTL1 sowie seiner Inhibitoren und Aktivatoren
CN105283466A (zh) * 2013-03-14 2016-01-27 安第斯生物技术股份有限公司 用于检测和治疗多发性骨髓瘤的方法
DE102021109341A1 (de) 2021-04-14 2022-10-20 TAVARGENIX GmbH TKTL1 Inhibitoren für die antivirale Therapie

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19527552C2 (de) * 1995-07-27 1999-06-24 Deutsches Krebsforsch Transketolase-verwandtes-Protein
US6333152B1 (en) * 1997-05-21 2001-12-25 The Johnshopkins University Gene expression profiles in normal and cancer cells
WO2000052204A2 (en) * 1999-02-22 2000-09-08 Orntoft Torben F Gene expression in bladder tumors
WO2001092310A2 (en) * 2000-05-31 2001-12-06 Bayer Aktiengesellschaft Regulation of human transketolase-like enzyme
US6727066B2 (en) * 2000-07-28 2004-04-27 Incyte Corporation Genes expressed in treated human C3A liver cell cultures
US20030235820A1 (en) * 2001-02-27 2003-12-25 Eos Biotechnology, Inc. Novel methods of diagnosis of metastatic colorectal cancer, compositions and methods of screening for modulators of metastatic colorectal cancer

Also Published As

Publication number Publication date
EP1354961B1 (de) 2008-01-23
DE60224778T2 (de) 2009-01-22
CN1646703A (zh) 2005-07-27
AU2003224067A1 (en) 2003-11-03
JP4239824B2 (ja) 2009-03-18
CN101684499A (zh) 2010-03-31
US20050158726A1 (en) 2005-07-21
CA2480276A1 (en) 2003-10-30
CA2480276C (en) 2011-09-13
JP2005523025A (ja) 2005-08-04
US20100136577A1 (en) 2010-06-03
US8216792B2 (en) 2012-07-10
EP1354961A1 (de) 2003-10-22
DE60224778D1 (de) 2008-03-13
ES2298304T3 (es) 2008-05-16
US7655398B2 (en) 2010-02-02
WO2003089667A1 (en) 2003-10-30
CN101955997A (zh) 2011-01-26

Similar Documents

Publication Publication Date Title
ATE519862T1 (de) Zusammensetzungen, kits und verfahren zur identifizierung, beurteilung, vorbeugung und therapie von gebärmutterhalskrebs
DE60130797D1 (de) Verwendung von spezifischen erbb4 antagonisten zur behandlung von stenose
IS7770A (is) Hlutleysandi mótefni gegn GDF-8 og notkun theirra
EP2006298A3 (de) Jugendliches Hämochromatose-Gen (HFE2A), Expressionsprodukte und Verwendungen davon
DE69921156D1 (de) Verwendung von 5ht-6 antagonisten zur behandlung adhd
DE60330181D1 (de) Actriib-fusionspolypeptide und verwendungen dafür
DE60028970D1 (de) An her2 bindende peptidverbindungen
ATE481978T1 (de) Zusammensetzungen und verfahren zur behandlung von herzkrankheiten
ATE540129T1 (de) Target zur therapie kognitiver behinderungen
MY140132A (en) Thiazolidin-4-one derivatives for use in the treatment of anemias
DE69732535D1 (de) Oligonucleotidzusammenstellung und verfahren zur regulierung der protein b7 expression
ATE473728T1 (de) Verwendung von fluoreszierenden perlylenverbindungen zur behandlung menschlicher haare
WO2003103581A3 (en) COMPOSITIONS AND METHODS FOR LIVER GROWTH AND PROTECTION
EA200600424A1 (ru) Применение полипептидов семейства купредоксинов при лечении рака
ATE358485T1 (de) Alpha-7-nikotinsäure-rezeptoragonisten und statine in kombination
DE69940206D1 (de) Verfahren zur behandlung von multiplem myelom und von myelom- induzierter knochenresorption mit antagonisten der integrin-/rezeptorbindung
ATE488529T1 (de) Zusammensetzungen und verfahren zur behandlung von tumoren
ATE534649T1 (de) Imidazothiazole und imidazoxazolderivative als inhibitoren von p38
MXPA05011085A (es) Composiciones y metodos relacionados a stop-1.
DE69705936D1 (de) Teil der intronsequenz des von hippel-lindau(vhl)-gens und seine verwendung zur krankheitsdiagnose
ATE313561T1 (de) Vgf polypeptide und verfahren zur behandlung von vgf-erkrankungen
ATE384804T1 (de) ZUSAMMENSETZUNGEN UND VERFAHREN ZUR BEHANDLUNG UND ZUR DETEKTION VON PROLIFERATIVEN STÖRUNGEN DIE MIT DER ÜBEREXPRESSION DES MENSCHLICHEN ßTRANSKETOLASE LIKE-1ß GENS IN ZUSAMMENHANG STEHEN
DK1234025T3 (da) Humane enzymer fra metalloproteasefamilien
DE60130565D1 (de) Pde8a und seine verwendung
ATE482217T1 (de) Dithiolopyrrolon-derivate zur behandlung von proliferativen störungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1354961

Country of ref document: EP